Fundamental Role of DPP-4 Inhibitors and GLP-1 Receptor Agonists

Based on an expanding and favorable literature describing their use in various patient populations, the guidelines of the American Association of Clinical Endocrinologists (AACE) and the recently updated guidelines from the American Diabetes Association (ADA) assign these agents a central role in the treatment of T2D (Endocrine Practice)